Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
21h
Flagship Harbor Advisors LLC cut its position in iShares 0-5 Year TIPS Bond ETF (NYSEARCA:STIP – Free Report) by 7.8% during ...
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback